MEKK-related signal transduction kinases
AssigneeNational Jewish Center for Immunology and Respiratory Medicine
InventorGary L. Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates to isolated MEKK proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to use such proteins to regulate signal transduction in a cell. The present invention also includes therapeutic compositions comprising such proteins or nucleic acid molecules that encode such proteins and their use to treat animals having medical disorders including cancer, inflammation, neurological disorders, autoimmune diseases, allergic reactions, and hormone-related diseases. When MEKK is expressed, it phosphorylates and activates MEKs including MEK-1, MEK-2 and JEK.
Claims11
An isolated MEKK protein comprising the amino acid sequence of SEQ ID NO:4.
An isolated MEKK regulatory domain comprising amino acids 1-162 of SEQ ID NO:4.
An isolated MEKK catalytic domain comprising amino acids 351-619 of SEQ ID NO:4.
An isolated MEKK kinase domain comprising amino acids 386-480 of SEQ ID NO:4.
An isolated MEKK protein comprising the amino acid sequence of SEQ ID NO:6.
An isolated MEKK regulatory domain comprising amino acids 1-174 of SEQ ID NO:6.
An isolated MEKK catalytic domain comprising amino acids 357-626 of SEQ ID NO:6.
An isolated MFKK kinase domain comprising amino acids 392-486 of SEQ ID NO:6.
An isolated MEKK protein comprising the amino acid sequence of SEQ ID NO:8.
An isolated MEKK protein comprising the amino acid sequence of SEQ ID NO:10.
An isolated MEKK kinase domain comprising amino acids 656-742 of SEQ ID NO:8.
Dependencies are inferred from the claim text.